Transparency and Clinical Trials in the EU

Loading Map....

Date(s) - 17/10/2019
13:00 CEST - 15:00 CEST

European Parliament


Since 2013, the European Parliament and other European Union (EU) institutions have endorsed reforms of clinical trial regulations that would ensure greater transparency and accountability. However, implementation of these essential amendments is being hindered due to a lack of commitment from a number of key actors.

Join Health Action International and TranspariMED  for a public discussion on the EU Clinical Trial Regulation and how it contributes to greater transparency. We will try to find answers to the following questions:

  • How can we ensure that transparency is enforced?
  • How can relevant stakeholders best utilise open and transparent clinical trial data for the benefit of patients?
  • What role should be played by the EU institutions?
  • How would recent efforts aimed at achieving greater transparency in R&D data link to greater accountability for clinical trials?


  • Fergus Sweeney | Head of Inspections, Human Medicines Pharmacovigilance and Committees Division, European Medicines Agency
  • Kristof Bonnarens | Policy Officer Pharmaceuticals, European Commission, DG Sante
  • Sylvia de Haan | Head of External Affairs & Geographic Groups’ Support, Cochrane
  • Rachel Cooper | Director, Transparency International Health Initiative
  • Till Bruckner | Founder, TranspariMED
  • Jaume Vidal | Senior Policy Advisor, Health Action International
  • Moderator: Rita Kessler | European Advocacy Officer, Prescrire

Please register by 11 October using following link:


Event Language is English, translation into French is offered. Light lunch will be provided.

See the Facebook Live video from the event:

Read the Tweets from the event:

Les législateurs de l'UE sonnent l'alarme sur le manque d'engagement à faire respecter la transparence des données des essais cliniques. Communiqué de Presse: #TransparentTrials

#EU lawmakers raise alarm at lack of commitment to enforcing clinical trial data #transparency. Read our latest press release: #TransparentTrials

Missed the public discussion on Transparency and Clinical Trials in the EU? Watch the full broadcast of the event now on our Facebook page: #TransparentTrials

.@EUombudsman strongly insists that clinical trials results should not be confidential (default) or made public due to overriding public interest. Hopefully ECJ will adequately reject opinion of Advocat General Hogan #TransparentTrials

Time for the Q&A for the Transparency and Clinical Trials in the EU public discussion in Brussels! Have your say by using #TransparentTrials, or join in via #FacebookLive:

Load More...